The 12-16-week open-label study evaluated Ruxoprubart as monotherapy in treatment-naïve PNH patients. Key findings include: CLEVELAND, March 09, 2026 (GLOBE NEWSWIRE) -- NovelMed Therapeutics Inc., a ...

In 2025, we were very pleased to report tremendous progress across all pillars of the company. First of all, in business development, we were delighted with the progress in our collaboration with MSD ...

The controlled-access divided highway is nothing short of an engineering marvel. High-speed, high-capacity, just point your car in a general direction and before you know it, the local accent or even ...

Smart homes are often defined by the technology inside them. But behind the scenes, lighting is what quietly powers the experience. From morning routines to evening relaxation, intelligent lighting ...

To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/5243/286598_aitx-rad-260309-1920×1080.jpg ...

The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...

When an AI system in health care gives a confident answer, should clinicians trust it? In a new article from Frontiers in ...

Ever felt like life hit the pause button, and suddenly, things are ready to move again? That’s exactly the vibe as Jupiter Direct in Gemini arrives in March 2026. After months of delays, mixed signals ...